drugset / Trial / NCT01279083

Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT01279083

Phase 1/2 Completed 147 enrolled Santen Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the safety and efficacy of DE-112 in lowering intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension.

Timeline

Start
2011-01
Primary completion
2011-11
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject EVODENOSON Small molecule Topical
Comparator Timolol Other / unclassified Topical